Drug releasing particles are valued for their ability to deliver therapeutics to targeted
locations and for their controllable release patterns. The development of microfluidic …

Novel nanocarriers such as multifunctional nanoparticles (NPs) have recently attracted
attention due to their various applications, specifically in medicine and treatment. However, it …

A drawback in the development of treatments that can reach the retina is the presence of
barriers in the eye that restrain compounds from reaching the target. Intravitreal injections …

Despite its prominent therapeutic efficacy, chemotherapy has raised serious concerns due to
the severe adverse effects and multidrug resistance evoked, which propels the search for …

Rivaroxaban (RVX), an oral direct factor Xa inhibitor, is being explored as an alternative to
traditional anticoagulans. However, RVX still faces pharmacokinetic limitations and adverse …

Bacterial infections represent one of the leading causes of mortality in the world. Among
causative pathogens, S. aureus is prominently known as the underlying cause of many …

Nanotherapeutics have gained significant attention for the treatment of numerous cancers,
primarily because they can accumulate in and/or selectively target tumors leading to …

Rifampicin (RFP) is a first‐line drug used to treat a variety of infections, including wound
infections but has limitations in its use due to its toxicity. Hence, an urgent need exists for the …

Microfluidic‐assisted particle fabrication provides a route to circumvent the disadvantages
associated with traditional methods of polymeric particle generation, such as low drug …

Nanotechnologies, such as nanoparticles (NPs) and nanomedicines (NMeds), show great
promise for treating and diagnosing central nervous system diseases due to features like …